Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2019

17.01.2019 | Short Research Report

Infectious diseases physician attitudes to long-term antibiotic use

verfasst von: Christopher R. Kiss, Jillian S. Y. Lau, Alex Yeung, Ian Woolley

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background In Australia, it is not known how much antibiotic prescribing by infectious diseases physicians is long-term, or how confident they are with the evidence behind this practice. Objective Survey Australian infectious diseases physicians to assess attitudes and prescribing practice prescribing prolonged courses of antibiotics. Methods An online questionnaire was distributed to the mailing group for the Australian Society of Infectious Diseases. Responses were collected from 29th October to 12th November 2015. Results The majority of respondents practiced in Australia as Infectious Diseases physicians, microbiologists, or trainees. 88% had prescribed long-term antibiotics. Heterogeneity was noted in the indications for prescription, including recurrent UTIs, cellulitis or chest infections, prosthetic joint infection and vascular graft infection. Beta-lactams antibiotics were prescribed most frequently. 22% of respondents had prescribed rifampicin/fusidic acid most frequently, while 11% could not identify a single antibiotic that they used most frequently, due to the heterogeneity of indications for prescribing. 95% stated that they would stop long-term antibiotic therapy if appropriate, and 74% were willing to enrol their patients into a randomised control trial looking at stopping long-term therapy. Conclusion Most infectious diseases physicians who responded to the survey prescribe long-term antibiotics, with great heterogeneity in the indications for which these antibiotics are prescribed.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13:551–8.CrossRefPubMed Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13:551–8.CrossRefPubMed
2.
Zurück zum Zitat Dason S, Dason J, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5:316–22.CrossRefPubMedPubMedCentral Dason S, Dason J, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5:316–22.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Stapleton A, Stamm W. Prevention of urinary tract infection. Infect Dis Clin North Am. 1997;11:719–33.CrossRefPubMed Stapleton A, Stamm W. Prevention of urinary tract infection. Infect Dis Clin North Am. 1997;11:719–33.CrossRefPubMed
4.
Zurück zum Zitat Jones P, Woolley I, Leder K, Spelman D, Cameron P, Cheng A. Postsplenectomy infection; strategies for prevention in general practice. Aust Fam Physician. 2010;39(6):383.PubMed Jones P, Woolley I, Leder K, Spelman D, Cameron P, Cheng A. Postsplenectomy infection; strategies for prevention in general practice. Aust Fam Physician. 2010;39(6):383.PubMed
5.
Zurück zum Zitat Osman D, Berbari E, Berendt A, Lew D, ZImmerli W, Steckelberg J. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infection diseases Society of Amrica. Clin Infect Dis. 2012;56(1):e1–25. Osman D, Berbari E, Berendt A, Lew D, ZImmerli W, Steckelberg J. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infection diseases Society of Amrica. Clin Infect Dis. 2012;56(1):e1–25.
6.
Zurück zum Zitat Baddour L. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322(4):209–12.CrossRefPubMed Baddour L. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci. 2001;322(4):209–12.CrossRefPubMed
7.
Zurück zum Zitat Lau J, Kiss C, Roberts E, Horne K, Korman T, Woolley I. Surveillance of life-long. antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network. Ann Clin Microbiol Antimicrob. 2017;16:3.CrossRefPubMedPubMedCentral Lau J, Kiss C, Roberts E, Horne K, Korman T, Woolley I. Surveillance of life-long. antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network. Ann Clin Microbiol Antimicrob. 2017;16:3.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Watson D. Ozbug: an email mailing list for physicians that works. Intern Med J. 2003;33(11):532–4.CrossRefPubMed Watson D. Ozbug: an email mailing list for physicians that works. Intern Med J. 2003;33(11):532–4.CrossRefPubMed
11.
Zurück zum Zitat Pushkin R, Iglesias-Ussel M, Keedy K, MacLauchlin C, Mould D, Berkowitz R, et al. A randomized study evaluating oral fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of- care antibiotics for treatment of prosthetic joint infections: a newly identified drug–drug interaction. Clin Infect Dis. 2016;15(12):1599–604.CrossRef Pushkin R, Iglesias-Ussel M, Keedy K, MacLauchlin C, Mould D, Berkowitz R, et al. A randomized study evaluating oral fusidic acid (CEM-102) in combination with oral rifampin compared with standard-of- care antibiotics for treatment of prosthetic joint infections: a newly identified drug–drug interaction. Clin Infect Dis. 2016;15(12):1599–604.CrossRef
12.
Zurück zum Zitat Lau JSY, Korman TM, Woolley I. Life-long antimicrobial therapy: where is the evidence? J Antimicrob Chemother. 2018;73(10):2601–12.CrossRefPubMed Lau JSY, Korman TM, Woolley I. Life-long antimicrobial therapy: where is the evidence? J Antimicrob Chemother. 2018;73(10):2601–12.CrossRefPubMed
Metadaten
Titel
Infectious diseases physician attitudes to long-term antibiotic use
verfasst von
Christopher R. Kiss
Jillian S. Y. Lau
Alex Yeung
Ian Woolley
Publikationsdatum
17.01.2019
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2019
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-00781-4

Weitere Artikel der Ausgabe 1/2019

International Journal of Clinical Pharmacy 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.